Summary
Introduction
Current evidence suggests that at least some types of high-molecular-weight renin are complexes of a low-molecular-weight renin and a renin-binding substance 1-71. Funakawa et al.
[81 and ourselves 13, 91 have demonstrated that renin is stored as a low-molecular-weight form ( M , approximately 40 OOO) in the renin granules of the dog and the rat, and that this renin binds to a renin-binding substance which is present in the renal cortex to form a high-molecular-weight renin ( M , approximately 60 000). Fundamental properties of the renin-binding substance were reported from our laboratory I3,71.
The reaction forming such a complex has also been studied. In dogs, rats and hogs the formation of renin-renin-binding substance complex in the kidney extract requires sulphydryl (SH) group oxidation [4, 5, 7, 81. However, whether the renin binds to the renin-binding substance with disulphide bond(s) or by the oxidation of some other substances which indirectly participate in the reaction is not known. In this study we attempted to clarify the role of SH oxidation in the mechanism of conversion between the high-and the low-molecular-weight renins.
Materials and methods

Tissue extracts
Fresh renal cortex of the dog was homogenized (1 :2, w/v) with phosphate buffer (50 mmol/l) containing NaCl (100 mmol/l), pH 7.2, and centrifuged at 100 000 g for 60 min to obtain crude extract of renal cortex. Renal medulla and liver were also homogenized and centrifuged to obtain crude extracts of these organs.
Renin
Renin granules were separated from the homogenate of renal cortex by discontinuous sucrose density gradient centrifugation [ 101. Renin in the granules was extracted by repeated freezing and thawing, and the renin then dissolved in phosphate buffer (50 mmol/l), pH 7.2, in a final concentration of 10 000 pmol of angiotensin I (ANG I) h-I ml-I. The molecular weight of renin was 40 000 by gel filtration.
Renin-binding substance
The renin-binding substance is in the renal cortex [3] . This substance is not bound with concanavalin A but renin is I 1 1 I. Accordingly, 5 ml of the cortical extract was subjected to affinity chromatography with concanavalin A Sepharose (Pharmacia Fine Chemicals) on a 0.8 cm x 10 cm column. Application to the column was repeated three times, and the column was then washed with 50 ml of phosphate buffer (50 mmol/l) containing NaCl (100 mmol/l), pH 7.2. The breakthrough fraction (approximately 60 ml) was concentrated to 5 ml with a Diafilter Membrane (Bioengineering Corp.). Preliminary tests proved that 1 ml of this preparation contained enough renin-binding substance to bind IOOOO pmol of ANG I/h in the presence of potassium tetrathionate (5 mmol/l) to form the high-molecdar weight renin.
High-molecular-weight renin
Potassium tetrathionate was added to the renal cortical extract to give a concentration of 10 mmol/l. After standing for 20 min at 15OC, the extract was dialysed against phosphate buffer (10 mmol/l) containing NaCl (20 mmol/l), pH 7.2, at 2OC for 24 h to remove potassium tetrathionate. This preparation contained high-molecularweight renin ( M , 60 OOO by gel filtration). One millilitre of this preparation had a renin activity of 20 OOO pmol of ANG I/h.
Thiopropyl Sepharose 6B afinity chromato-
A thiopropyl Sepharose 6B (Pharmacia Fine Chemicals) column (0.8 cm x 10 cm) was used. The column was equilibrated with phosphate graphy buffer (50 mmol/l) containing NaCl (100 mmol/ 1) and disodium EDTA (10 mmol/l), pH 7.2. One millilitre of the renin solution or the renal cortical extract was applied to the column and then the column was washed with 50 ml of the above buffer. Adsorbed substances were eluted with phosphate buffer (50 mmol/l) containing NaCI, (100 mmol/l), disodium-EDTA (10 mmol/l) and dithiothreitol (50 mmol/l), pH 7.2. Five millilitre fractions were collected with a Toyo Fraction Collector, model SF-160K. Proteins were monitored by an ISCO absorbance/fluorescence monitor. model UA-5.
Estimation of molecular weight
The molecular weight of renin was estimated by gel filtration on Sephadex G-100 (Pharmacia Fine Chemicals) as described before 131.
Renin assay
Renin activity was measured by radioimmunoassay of ANG I generated by incubation at 37OC [12] . The incubation mixture consisted of 0.05 ml of sample, 0.05 ml of semipurified dog angiotensinogen (5000 pmol of ANG I/ml) and 0.4 ml of phosphate buffer (50 mmol/l) containing disodium EDTA (10 mmol/l), 2,3-dimercaptopropan-1-01 (3.2 mmol/l) and 8-hydroxyquinoline sulphate (1 -6 mmol/l), pH 6.8). The reaction was stopped by immediate cooling after incubation for 15 min or 30 min. Semipurified angiotensinogen of the dog was prepared by the method of Morimoto et al. 131 .
Sulphydryl group blocking agent
In order to block the SH groups of the renin and the renin-binding substance, 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) [ 141 was used. The compound was dissolved in phosphate buffer (50 mmol/l), pH 7.2, and was added immediately to the renin solution and the renal cortical extract at a concentration of 10 mmol/l at pH 7.8. mmol/l) was added to the mixture before gel filtration, a single peak of the activity was found in the region of about M, 60000. Thus the molecular-weight conversion of renin was able to occur in this reaction mixture of renin-binding substance.
ThiopropyI Sepharose 4B afinity chrornatography of the renin and the renin-binding substance
As shown in Fig. 2(u) , when aliquots of the renin solution were applied to the a n i t y column, renin activity was barely detectable in the breakthrough fractions, but the activity appeared in the retarded fractions when these were subsequently eluted with the buffer containing dithiothreitol (50 mmol/l). The effect of a SH blocking agent on the chromatographic profile of renin was next examined. Addition of DTNB (10 mmol/l) to the renin solution resulted in the development of yellow 5-mercapto-2-nitrobenzoic acid, which was liberated from DTNB as a by-product of the reaction of protein SH with DTNB, indicating that the SH blocking reaction had proceeded. The renin activity of the solution was not changed by the treatment. After dialysis against phosphate buffer (10 mmol/l) containing NaCl (20 mmol/l), pH 7.2, for 24 h to remove this coloured compound and unchanged DTNB, the sample was applied to the d n i t y column. As shown in Fig. 2(b) , renin was demonstrated in the breakthrough fractions but not in the retarded fractions. These results clearly indicated that canine renal renin has an SH moiety($.
Whether the renin-binding substance has SH groups was next examined. One millilitre of the renal cortical extract was applied to the affinity 0 .. column. All the breakthrough fractions (60 ml) were pooled and concentrated to 1 ml with a Diafilter membrane. The concentrated sample was mixed with 1 ml of the renin solution. The retarded fractions (50 ml) were also concentrated to 1 ml and then dialysed against phosphate buffer (10 mmol/l) containing NaCI, (20 mmol/l), pH 7.2, to remove dithiothreitol. Both samples were used to examine the molecular weight of renin in the presence of potassium tetrathionate (5 mmol/l), but in neither the breakthrough fractions nor the retarded fractions was low-molecular-weight renin converted into high-molecular-weight renin. Thus we failed to demonstrate the renin-binding substance in both fractions.
Eflect of sulphydryl group blocking agent on the formation of high-molecular-weight renin
To assess the role of SH groups of renin in the molecular-weight conversion, the following experiments were performed. DTNB (10 mmol/l) was added to the renin solution, dialysed for 24 h and then mixed with the renin-binding substance renin-binding substance was capable of reacting with SH-blocked renin, although the reaction was rather incomplete (Fig. 3) . Furthermore, addition of DTNB alone (10 mmol/l) to the renal cortical extract also resulted in the appearance of highmolecular-weight renin. Thus blocking S H groups with DTNB or with potassium tetrathionate was required, but the S H of renin does not contribute to the reaction of renin with the renin-binding substance.
Conversion of the high-molecular-weight renin to the low-molecular weight form by tissue extracts
The above results led us to the inference that the renin does not bind to the renin-binding substance by means of a disulphide bond, despite of the necessity of S H oxidation in the reaction system. If this conclusion is valid, the binding might involve other modes of reaction. For instance, a factor which is activatable by S H oxidation might be involved in the binding reaction. Another possible factor is a S H group enzyme which promotes the reverse reaction by which the high-molecular-weight renin is converted into the low-molecular-weight form. If such an enzyme exists and is inhibited by S H oxidation, the high-molecular-weight renin would not be converted into the low-molecular-weight form. To test this hypothesis, the high-molecularweight renin was mixed with the extract of renal cortex (1 : 1, v/v) and was incubated.
After incubation with the renal cortical extract at 37OC for 15 min, total renin activity was about twice that of the high-molecular-weight renin in a given volume. Since the sample included both the high-and the low-molecular-weight renins, gel filtration should reveal two major peaks of renin activity if the renal cortical extract does not affect the molecular weight of the high-molecular weight renin. However, gel filtration revealed only a single peak of renin activity at the molecular weight of 40 000, indicating that the molecular Since the renal cortical cytosol contained renin, there was a higher activity of renin in (b) than in (a).
weight of the high-molecular-weight renin had been reduced (Fig. 4b) . We next examined extracts of liver and renal medulla. With liver, no change in total renin activity was observed, and only the low-molecular-weight renin was revealed by gel filtration; this result indicated that this low-molecular-weight renin had originated from the high-molecular-weight renin, for the liver extract contained no appreciable amount of renin (Fig. 4c) . With renal medulla, however, n o change in the molecular weight of renin was observed (Fig. 4 4 . When the extracts of renal cortex and liver were treated with 0.1 vol. of 6% perchloric acid (after centrifugation the deproteinized samples were neutralized with NaHCO,), the molecular weight of renin was unchanged. When potassium tetrathionate (5 mmolh) was added to the extracts of renal cortex and liver and then dialysed, again the molecular weight of renin was unchanged.
Discussion
The present work has demonstrated that canine renal renin possesses an SH moiety(s). The SH moiety($ of the renin is not, however, located in the active centre of the enzyme, since the SH group blocking agent DTNB did not affect its activity. Some papers have also documented no appreciable inhibitory effect of N-ethylmaleimide or of sodium tetrathionate on the activity of renin, although they did not describe the existence of SH groups in the renin [4, 151.
In hogs, rabbits, dogs and rats the highmolecular-weight renin is thought to be a complex of renin and a renin-binding substance [1-71. In dogs and rats, the high-molecular-weight renin is formed by reagents which cause SH oxidation [4, 7, 8, 161. Does the renin bind to renin-binding substance by means of disulphide bond(s)? DTNB, like N-ethylmaleimide, acts by blocking SH groups. Nevertheless, renin was found to be capable of reaction with the renin-binding substance even after it was treated with DTNB. In this experiment, DTNB might affect the structure of renin or the renin-binding substance, and this might be the cause of incomplete formation of the high-molecular-weight renin. However, addition of DTNB to the renal cortical extract also resulted in the formation of the high-molecularweight renin. In addition, in rats, the SH group alkylating agent N-ethylmaleimide has been reported to cause the formation of highmolecular-weight renin [4]. Murakami er al. [171 also reported the formation of high-molecularweight renin by DTNB and by N-ethylmaleimide in hog kidney. This evidence strongly suggests that the formation of the renin-renin-binding substance complex does not require the SH groups of renin. Thus, if disulphide bonds do not contribute to the formation of high-molecularweight renin, some other mechanisms, e.g. catalytic factor, might be involved in the mechanism of conversion.
Considering this aspect further, the reaction of molecular weight conversion of renin can be expressed by the following equation:
where LMW is the low-molecular-weight renin, RBS is the renin-binding substance and HMW is the high-molecular-weight renin. In this equation either the reaction (R,) or the reverse reaction (RJ may involve a SH-related enzyme. R , is known to be preceded by SH oxidation, and its catalysis by an enzyme which is activatable by SH oxidation is a possibility. Alternatively, an SH-activated enzyme may also be involved in R,. The latter alternative is more probable. Indeed, we found that extracts of renal cortex and liver contain a factor which converts high-molecular-weight renin into the low-molecular-weight form. The factor involved was non-dialysable, was precipitated by perchloric acid and was inactivated by potassium tetrathionate, indicating that it is an SH-activated protein. Moreover, it should be emphasized that the factor did not affect the activity of renin. Thus the existence of an SH-activated enzyme-like agent which alters the molecular weight without appreciably changing the activity of renin is postulated. Such a substance may be specifically distributed among organs.
In dogs, high-molecular-weight renin is not an inactive form. Accordingly, the renin-binding substance is not an inhibitor of renin, and its physiological role is unclear. However, the enzyme system proposed herein may provide information which is valuable for a better understanding of the mechanism of molecular weight changes of renin and of the significance of the renin-binding substance in the cascade of the renin-angiotensin system.
